CZA:NYE-Invesco Zacks Mid-Cap ETF (USD)

ETF | Mid-Cap Blend |

Last Closing

USD 107.25

Change

-0.56 (-0.52)%

Market Cap

N/A

Volume

1.00K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Mid-Cap Blend

Symbol Name Price(Change) Market Cap
IJH iShares Core S&P Mid-Cap ETF

-0.20 (-0.32%)

USD 91.24B
IWR iShares Russell Mid-Cap ETF

-0.35 (-0.40%)

USD 36.18B
MDY SPDR® S&P MIDCAP 400 ETF Trus..

-1.49 (-0.26%)

USD 23.21B
VXF Vanguard Extended Market Index..

-0.79 (-0.44%)

USD 20.35B
SPMD SPDR Russell Small Cap Complet..

-0.14 (-0.26%)

USD 11.24B
XMHQ Invesco S&P MidCap Quality ETF

-0.33 (-0.32%)

USD 5.69B
JHMM John Hancock Multifactor Mid C..

-0.17 (-0.28%)

USD 4.01B
IVOO Vanguard S&P Mid-Cap 400 Index..

-0.27 (-0.26%)

USD 2.25B
EQAL Invesco Russell 1000 Equal Wei..

-0.14 (-0.29%)

USD 0.62B
FSMD Fidelity Small-Mid Factor

-0.20 (-0.49%)

USD 0.49B

ETFs Containing CZA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Blend) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.33% 94% A 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.33% 83% B 62% D
Trailing 12 Months  
Capital Gain 28.20% 68% D+ 70% C-
Dividend Return 1.53% 33% F 20% F
Total Return 29.73% 58% F 66% D+
Trailing 5 Years  
Capital Gain 50.04% 11% F 70% C-
Dividend Return 8.13% 56% F 25% F
Total Return 58.17% 11% F 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.78% N/A N/A 70% C-
Dividend Return 12.21% N/A N/A 67% D+
Total Return 1.43% N/A N/A 33% F
Risk Return Profile  
Volatility (Standard Deviation) 19.26% N/A N/A 53% F
Risk Adjusted Return 63.39% N/A N/A 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike